CYPH - Cypherpunk Technologies Inc.

Stock Grade Analysis

General Rating

C+
Overall Score: 2/5
Multi-dimensional Scores
DCF: 3/5 ROE: 1/5 ROA: 1/5 D/E: 4/5 P/E: 1/5
Financial Ratios Trend

Grades Consensus

0

Strong Buy

7

Buy

0

Hold

0

Sell

0

Strong Sell

Buy

Consensus

Grade News & Updates

Date Grading Company New Grade Previous Grade Action Price When Posted News Title Publisher
2024-06-28 Rodman & Renshaw Buy N/A Initialise $1.77 Leap Therapeutics initiated with a Buy at Rodman & Renshaw TheFly
2024-05-14 H.C. Wainwright Buy Buy Hold $2.83 Leap Therapeutics price target lowered to $5.50 from $7 at … TheFly
2023-11-14 Raymond James Outperform Outperform Hold $1.49 Raymond James Maintains Outperform Rating for Leap Therapeu… Benzinga
2022-11-11 Raymond James Outperform Outperform Hold $6.195 Raymond James Maintains Outperform on Leap Therapeutics, Lo… Benzinga